Doxorubicin Hydrochloride Micelles (Curelon(Beijing)Pharmaceutical)

盐酸多柔比星胶束（开瑞龙）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameDoxorubicin Hydrochloride Micelles (Curelon(Beijing)Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsDNATopoisomerase II
Therapy Area/IndicationsMetastatic breast cancerStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCurelon(Beijing)Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biophysics, Chinese Academy Of SciencesCurelon(Beijing)Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A